Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Drug Delivery Devices Market from 2024 to 2025?#_x000D_

There’s been significant growth in recent years in the market size for drug delivery devices. It’s predicted to expand from $91.03 billion in 2024 to $96.73 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.3%. The surge during the historic timeframe is linked to factors such as the fast-aging population, an increase in the quantity of healthcare facilities, emerging market economies, and higher healthcare spending._x000D_

_x000D_

#What Is the Projected Market Size of the Drug Delivery Devices Market?#_x000D_

The market for drug delivery devices is projected to experience robust growth in the coming years, escalating to $124.82 billion by 2029 at a CAGR of 6.6%. This growth during the projected timeframe can be credited to the rising occurrence of chronic diseases, an upward trend in demand for injectables, increased need for drug delivery devices, and the abrupt rise of severe infections. The primary trends anticipated during the forecast period involve investments in microneedle drug delivery technology, the pursuit of research and development in self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Drug Delivery Devices Market Outlook?#_x000D_

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc_x000D_

_x000D_

#What Is Fueling Growth in the Drug Delivery Devices Market?#_x000D_

The escalating occurrence of chronic illnesses such as heart disease, diabetes, cancer, and other ailments is projected to propel the drug delivery devices market forward. For example, the National Library of Medicine, a U.S.-based federally operated medical library, reported in January 2023 that the count of individuals in the United States aged 50 and older with one chronic ailment at least is expected to surge by 99.5%. This surge would raise the count from 71.522 million in 2020 to 142.66 million by 2050. There are many modes of administering medication for medical drugs. The innovation of new drug delivery systems is crucial in the pharmaceutical sector. Worldwide, research and development (R&D) in drug delivery are growing due increase in these diseases. The majority of pharmaceutical companies are prioritizing various drug delivery technologies to yield superior benefits and improved results for their marketed products. Consequently, the rising occurrence of chronic diseases that result in an increased use of therapeutic drugs and therapies is anticipated to serve as a catalyst for the expansion of the drug delivery devices market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp_x000D_

_x000D_

#Which Drug Delivery Devices Market Segments Are Growing the Fastest?#_x000D_

The drug delivery devices market covered in this report is segmented –_x000D_

_x000D_

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery_x000D_

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings_x000D_

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets_x000D_

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps_x000D_

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders_x000D_

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems_x000D_

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers_x000D_

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops_x000D_

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films_x000D_

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Drug Delivery Devices Market?#_x000D_

Leading businesses in the drug delivery device market are concentrating their efforts on creating groundbreaking devices like autoinjectors that are fully integrated with connectivity in order to excel in the market. Autoinjectors are specialized devices intended for individual application of a predetermined medication dosage. To illustrate, Jabil Healthcare, a healthcare manufacturing solutions provider based in the US, rolled out the Qfinity autoinjector platform, a reliable reusable drug delivery device, in May 2022. The Qfinity platform distinguishes itself as an uncomplicated, reusable, and modular approach to self-administering subcutaneous drugs. It provides an economical alternative to market rivals, advancing sustainable drug distribution in the pharmaceutical sector. Its adaptable design adapts to different drug volumes and viscosities. The patient-friendly design allows for up to 65% reduction in the cost per injection compared to top disposable autoinjectors on the market. The robust Qfinity device is capable of supporting over 100 injections and uses 1 mL or 2.25 mL prefilled disposable cassettes. Furthermore, it reduces the usage of components and materials which leads to an estimated 65% drop in cost per injection, a 60% smaller carbon footprint, 50% shrinkage in manufacturing footprint, and a 70% cutback in capital expenditure (CAPEX)._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Drug Delivery Devices Market?#_x000D_

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the drug delivery devices market, and how is it changing globally?_x000D_

2. Who are the major companies in the drug delivery devices market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the drug delivery devices market right now?_x000D_

4. Which products or customer segments are growing the most in the drug delivery devices market?_x000D_

5. What factors are helping or slowing down the growth of the drug delivery devices market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model